A phase II study of ibrutinib and short-course fludarabine in previously untreated patients with chronic lymphocytic leukemia.

ABSTRACT:

SUBMITTER: Pleyer C 

PROVIDER: S-EPMC8932338 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature